U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746336) titled 'Treatment Based on High Precision Cardiac Mapping' on July 20.
Brief Summary: APOLO-VT aims to evaluate the feasibility, safety, and clinical impact of an integrated multimodal mapping workflow combining non-invasive structural and functional substrate characterization using Volumetric Electrocardiographic Imaging (ECGi) with invasive Electroanatomical Mapping (EAM) to support Ventricular tachycardia (VT) ablation targeting and verification.
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
VT Ablation
Arrhythmic Burden
Implantable Cardioverter-Defibrillator (ICD) Therapies
Slow-conduction Substrate
Intervention: ...